泪道疏通联合典必殊眼膏留置治疗泪道阻塞

Treating lacrimal ducts obstruction by dredged combining injecting Tobradex ointment into lacrimal passage

目的:观察泪道探通、激光泪道成形术联合典必殊眼膏泪道注药留置治疗泪道阻塞的临床疗效。方法:接受泪道探通、激光泪道成形术的患者128例196眼,术中联合泪道注入典必殊眼膏,术后每5～7d酌情再次或多次注药,回顾分析应用效果。结果:泪道探通联合注药154眼,有效119眼,有效率为77.3%;激光泪道成形联合注药42眼,有效34眼,有效率为81.0%;总有效率为78.1%。结论:典必殊眼膏泪道注药留置在泪道探通、激光泪道成形术联合应用具有较好疗效。

AIM： To study and analyze the dinical effect of probing of lacrimal passages, transcanalicular laser-assisted dacryocystoplasty combining injecting Tobradex ointment into lacrimal passage in the treatment of lacrimal ducts obstruction. METHODS： A total of 128 patients （196 eyes） with lacrimal ducts obstruction were treated with probing of lacrimal passages or transcanalicular laser-assisted dacryocystoplasty. Meanwhile, all of them were injected with Tobradex ointment into their lacrimal passage. Then every 5-7 days after treatment, Tobradex ointment was injected again according to the patients＇ reaction. The effects were retrospectively analyzed. RESULTS： Among the 154 eyes treated by probing of lacrimal passages and Tobradex ointment injection, the treatment was effective in 119 eyes （77.3%）. Among the 42 eyes treated by transcanalicular laser-assisted dacryocystoplasty and Tobradex ointment injection, the treatment was effective in 34 eyes （81.0%）. The total effective rates were 78.1%. CONCLUSION： Injection of Tobradex ointment after probing of lacrimal passages or transcanalicutar laser-assisted dacryocystoplasty is an effective treatment for lacrimal ducts obstruction.